Lansoprazole Capsule, Delayed Release
Product Images NDC 0536-1368

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 0536-1368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

This is a drug information sheet for Lansoprazole Delayed-Release Capsules, USP containing 15mg of Lansoprazole USP. It is an acid reducer used to treat frequent heartburn. The recommended dosage is one capsule a day, taken approximately 30 minutes before eating. It is packaged in a bottle containing 42 capsules, and a tamper-evident seal is provided beneath the cap. The label includes important warnings and directions, precautions, and notes for users. The product contains both active and inactive ingredients and may interact with other prescription drugs. If symptoms persist after 14 days of use, users should seek medical advice.*

FDA Label Image

Container (Container)

This is a product label for delayed-release capsules with the active ingredient Lansoprazole, used to treat frequent heartburn as an acid reducer. It contains 14 capsules, and a 14-day treatment course may take 1-4 days for full effect. The label features information on the distributor, Rugby Laboratories, and manufacturing origin in India. There are also instructions for use, warnings about tampering, and a website for more information. The remainder of the text appears to be garbled and not relevant.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.